TODAY : Monday, 21 April 2025
Code
RSCH
Title
PT. Charlie Hospital Semarang Tbk
Address
Head Office:
Address:Jl. Raya Ngabean Kav. 1A
Kel. Ngabean, Kec. Boja, Kb. Kendal, Jawa Tengah 51381
Phone:(024) 8600 5000
Fax:-
E-mail:corsec@charliehospital.co.id
Website:https://charliehospital.co.id/
Background

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.


Business cp product

The Company is engaged in the activities of private hospitals. The Company's hospital is classified as a type D hospital,


Subsidiary affiliation
Commissioners
President Commissioner: Wahyu Fitrianingsih
Independent Commissioner: Roy Octavian
Per Sep 30, 2023
Directors
President Director: Junianto
Director: Sri Mulyaningsih
Per Sep 30, 2023
Underwriter
PT. Shinhan Sekuritas Indonesia
Share registrar
PT. Adimitra Jasa Korpora
Share holders
ShareholdersShares%
PT Wahyu Agung2,105,000,00079.43
Wahyu Fitrianingsih7,500,0000.28
Junianto6,760,0000.26
Sri Mulyaningsih740,0000.03
Public530,000,00020.00
As of Sep 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp 11528-Aug-202350530,000,0002,650,000,000

Other infos



Value of Initial Public Offering : total of IDR 60,950,000,000



Public Offering Period: 22 ? 24 August 2023

Created date
2024-03-26 13:23:02
Revised date
2024-03-26 15:50:38
Finance
 
PT. Charlie Hospital Semarang Tbk
 
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year
2020-12-31
Dec
12
 
 
31,389,331.00
581,156,612.00
65,633,371.00
683,524,350.00
4,953,257,018.00
0.00
4,953,257,018.00
5,636,781,368.00
126,394,261.00
1,291,313,198.00
1,417,707,459.00
5,000.00
5,000,000,000.00
1,000,000.00
5,000.00
-780,926,091.00
4,219,073,909.00
0.00
 
 
1,326,414,361.00
862,034,949.00
464,379,411.00
-390,481,367.00
2,175,349.00
-388,306,018.00
0.00
-388,306,018.00
0.00
 
 
-7,766,120.00
84,381,478.00
 
 
34.00
-689.00
-920.00
-2,927.00
-2,944.00
3,501.00
24.00
 
 
-502,772,756.00
-395,130,701.00
897,423,837.00
-479,621.00
31,868,952.00
31,389,331.00